Objective
To assess the clinical outcome of chemical synovectomy with rifampicin in hemophilic arthropathy by using the World Federation of Hemophilia (WFH) scoring system and plain radiograph.
Methods
We performed rifampicin synovectomy (RS) on 30 joints of 28 hemophilic patients diagnosed as hemophilic arthropathy stage I–III (based on Fernandez-Palazzi clinical classification). Clinical status (bleeding frequency, pain, joint physical status) and radiological staging were evaluated as parts of the WFH scoring system before and 1 year after RS. The patients were divided into two groups by the Arnold-Hilgartner scale of the initial X-ray as stage 3 or less for the low-stage group (n=17) and over 3 for the high-stage group (n=13).
Results
Total WFH joint physical scores were reduced after injection, and the number of bleeding episodes and pain showed especially significant improvement. For other subscores of the WFH joint physical score, only swelling, range of motion, and crepitus showed statistically significant improvement. According to the severity of the radiologic finding, the WFH joint physical score of both the low-stage and high-stage groups showed significant improvement. In the radiological aspect, the low-stage group, without joint space narrowing at the initial plain radiograph, showed no further aggravation after injection. However, in the high-stage group, radiology found aggravation regardless of the procedure.
Conclusion
It is suggested that chemical synovectomy with rifampicin may prevent hemarthrosis and improve clinical symptoms. Especially in the early stage of arthropathy without joint-space narrowing, it seems to have an additional benefit that delays radiological aggravation and preserves joint status.

Citations

• Global trends in hemophilic arthropathy research: a bibliometric and visualization analysis
  Zhihao Wei, Lijun Ou, Sheng Chai, Dongdong Zhang, Gangjian Tang
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Rifampicin-Induced Toxic Hepatitis in a Patient with Hemophilia After Chemical Synovectomy
  Mehmet Can Uğur, Semih Aydoğdu, Elçil Kaya Biçer, Can Balkan, Kaan Kavaklı
  Turkish Journal of Hematology.2024; : 64.     CrossRef
• Ultrasound-guided joint procedures in hemophilia: technique, indications and tips
  Hortensia De la Corte-Rodriguez, E. Carlos Rodriguez-Merchan, M. Teresa Alvarez-Roman, Primitivo Gomez-Cardero, Victor Jimenez-Yuste
  Expert Review of Hematology.2024; 17(8): 419.     CrossRef
• Synovitis in hemophilia: preventing, detecting, and treating joint bleeds
  E. Carlos Rodriguez-Merchan
  Expert Review of Hematology.2023; 16(7): 525.     CrossRef
• Hemophilic arthropathy: how to diagnose subclinical bleeding early and how to orthopedically treat a damaged joint
  E. Carlos Rodriguez-Merchan
  Expert Review of Hematology.2023; 16(9): 651.     CrossRef
• The role of intraarticular injections of hyaluronic acid in joint pain relief in hemophilic arthropathy
  E. Carlos Rodriguez-Merchan
  Expert Review of Hematology.2023; 16(11): 811.     CrossRef
• Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report
  Roberta Gualtierotti, Claudio De Magistris, Eugenia Biguzzi, Jacopo Acquati Lozej, Alessandra Iurlo, Luigi Piero Solimeno, Flora Peyvandi
  Rheumatology and Therapy.2022; 9(5): 1465.     CrossRef
• Radiosynovectomy for the Treatment of Chronic Hemophilic Synovitis: An Old Technique, but Still Very Effective
  Emerito Carlos Rodriguez-Merchan, Hortensia De la Corte-Rodriguez, Maria Teresa Alvarez-Roman, Primitivo Gomez-Cardero, Victor Jimenez-Yuste
  Journal of Clinical Medicine.2022; 11(24): 7475.     CrossRef
• Synovitis and synovectomy in haemophilia
  Lize F. D. van Vulpen, Sylvia Thomas, Swapnil A. Keny, Shubhranshu S. Mohanty
  Haemophilia.2021; 27(S3): 96.     CrossRef
• Low‐dose surgical prophylaxis: Optimization of use of World Federation of Hemophilia Humanitarian Aid donated clotting factor concentrates to developing countries
  Magdy El Ekiaby, Assad Haffar
  Haemophilia.2020; 26(S3): 11.     CrossRef